Pfizer to buy Allergan in $160 billion deal – Reuters


Reuters

Pfizer to buy Allergan in $160 billion deal
Reuters
NEW YORK Pfizer Inc on Monday said it would buy Botox maker Allergan Plc in a deal worth $160 billion to slash its U.S. tax bill, rekindling a fierce political debate over the financial maneuver. The acquisition, which would shift Pfizer’s headquarters
Pfizer gobbles up tax advantages in a turkey of a transactionWashington Post
Experts: Treasury unlikely to block Pfizer-Allergan dealUSA TODAY
Don’t Hate Pfizer’s Tax InversionZacks.com
International Business Times –Wall Street Journal –Morningstar
all 1,272 news articles »


Source: Google News

Related posts